MicrobiologybioRxiv
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies
L. A. VanBlargan, J. M. Errico, P. Halfmann…·M. Diamond
This study evaluates the neutralization of the SARS-CoV-2 Omicron variant by therapeutic monoclonal antibodies and finds that several lose efficacy against the variant.
DOI 10.1038/s41591-021-01678-y